• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

IQVIA

How the clinical trial industry is making the most of COVID-19 disruption

December 30, 2020 By Brian Buntz

Like most things in healthcare, clinical trials have been slow to evolve in recent decades. But the COVID-19 pandemic has forced clinical trial research teams to become more efficient, patient-centered and inclusive.   Much is at stake as the pandemic has already caused significant clinical trial disruption. EY estimates that the COVID-19 impact on Phase 3 […]

Filed Under: Clinical Trials, Digital Health, Featured, Pharmaceutical Tagged With: Clinical Trials, coronavirus, COVID-19, external comparators, Gilead Sciences, IQVIA, real-world evidence, RWE, synthetic data

10 trends that will matter for life sciences in 2021

December 14, 2020 By Brian Buntz

One silver lining of the COVID-19 pandemic is that it has accelerated the rate of change for pharma and life sciences fields in general.  The pandemic has forced a rethink of how to manage clinical trials and treat patients in hospitals and their homes. And the breakneck speed of vaccine development in 2020 could potentially […]

Filed Under: Clinical Trials, Digital Health Tagged With: Biofourmis, CCT Research, Clinical Trials, contract research organizations, coronavirus, COVID-19, COVID-19 vaccine, CROs, Digital therapeutics, GlobalData, HealthMyne, InsightRX, IQVIA, life sciences, life sciences value chain, Linguamatics, natural language processing, NLP, SAP, specialty drugs, supply chain, ThreadThread Thread

How AI could reassure you that COVID-19 vaccines are safe

November 12, 2020 By Brian Buntz

As governments and health authorities worldwide gear up to deliver potentially billions of COVID-19 vaccine doses, artificial intelligence and data automation techniques could be a powerful tool combating one of the top hindrances to mass vaccination: vaccine hesitancy. In particular, natural language processing (NLP) could help health authorities transform adverse event reports from COVID-19 vaccines […]

Filed Under: Big Data, Electronic Medical Records (EMR), Health Technology, Software / IT Tagged With: adverse events, coronavirus, COVID-19, IQVIA, natural language processing, NLP

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS